APA

Husson R. N., Chung Y., Mordenti J., Butler K. M., Chen S., Duliege A. M., Brouwers P., Jarosinski P., Mueller B. U. & Ammann A. (19921113). Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection. : The Journal of pediatrics.

Chicago

Husson R N, Chung Y, Mordenti J, Butler K M, Chen S, Duliege A M, Brouwers P, Jarosinski P, Mueller B U and Ammann A. 19921113. Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection. : The Journal of pediatrics.

Harvard

Husson R. N., Chung Y., Mordenti J., Butler K. M., Chen S., Duliege A. M., Brouwers P., Jarosinski P., Mueller B. U. and Ammann A. (19921113). Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection. : The Journal of pediatrics.

MLA

Husson R N, Chung Y, Mordenti J, Butler K M, Chen S, Duliege A M, Brouwers P, Jarosinski P, Mueller B U and Ammann A. Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection. : The Journal of pediatrics. 19921113.